Patents by Inventor Christoph SAGER

Christoph SAGER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HYDROXYHETEROCYCLOALKANE-CARBAMOYL DERIVATIVES
    Publication number: 20240124427
    Abstract: The present invention relates to compounds of Formula (I) wherein X, Ar1, Ar2, L, n, m, and R1 are as described in the description, their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of Formula (I), and especially to their use as Galectin-3 inhibitors.
    Type: Application
    Filed: February 8, 2022
    Publication date: April 18, 2024
    Inventors: Martin BOLLI, John GATFIELD, Corinna GRISOSTOMI, Lubos REMEN, Christoph SAGER, Cornelia ZUMBRUNN
  • TRIAZOLYL-METHYL SUBSTITUTED ALPHA-D-GALACTOPYRANOSIDE DERIVATIVES
    Publication number: 20240109930
    Abstract: The present invention relates to Galectin-3 inhibitors of Formula (I) and pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising such compounds, and their medical uses.
    Type: Application
    Filed: March 2, 2022
    Publication date: April 4, 2024
    Inventors: Martin BOLLI, John GATFIELD, Corinna GRISOSTOMI, Lubos REMEN, Christoph SAGER, Cornelia ZUMBRUNN
  • GALECTIN-3 INHIBITING 2-HYDROXYCYCLOALKANE-1-CARBAMOYL DERIVATIVES
    Publication number: 20230348442
    Abstract: The present invention relates to compounds of Formula (I) wherein Ar1, Ar2, L, n, and R1 are as described in the description, their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of Formula (I), and especially to their use as Galectin-3 inhibitors.
    Type: Application
    Filed: November 1, 2021
    Publication date: November 2, 2023
    Inventors: Martin BOLLI, John GATFIELD, Corinna GRISOSTOMI, Lubos REMEN, Christoph SAGER, Cornelia ZUMBRUNN
  • SPIRO DERIVATIVES OF ALPHA-D-GALACTOPYRANOSIDES
    Publication number: 20230295182
    Abstract: The present invention relates to compounds of Formula (I) wherein Ar1, A, B, and R1 are as described in the description, their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of Formula (I), and especially to their use as Galectin-3 inhibitors.
    Type: Application
    Filed: October 5, 2021
    Publication date: September 21, 2023
    Inventors: Martin BOLLLI, John GATFIELD, Corinna GRISOSTOMI, Lubos REMEN, Christoph SAGER, Cornelia ZUMBRUNN
  • 2-HYDROXYCYCLOALKANE-1-CARBAMOYL DERIVATIVES
    Publication number: 20220324847
    Abstract: The present invention relates to compounds of Formula (I) wherein Ar1, Ar2, L, n, and R1 are as described in the description, their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of Formula (I), and especially to their use as Galectin-3 inhibitors.
    Type: Application
    Filed: August 14, 2020
    Publication date: October 13, 2022
    Inventors: Martin BOLLI, John GATFIELD, Corinna GRISOSTOMI, Lubos REMEN, Christoph SAGER, Cornelia ZUMBRUNN
  • ALPHA-D-GALACTOPYRANOSIDE DERIVATIVES
    Publication number: 20220281855
    Abstract: The present invention relates to compounds of Formula (I) wherein Ar1, R1 and R2 are as described in the description, and A is 4,5-dihydroisoxazole-3,5-diyl, imidazolidin-4-one-1,3-diyl, oxazol-2-one-3,5-diyl and oxazolidine-2-one-3,5-diyl, 1,2,3-triazole-1,4-diyl, isoxazole-3,5-diyl, imidazole-1, 4-diyl, and isothiazole-3,5-diyl; and their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of Formula (I), and especially to their use as Galectin-3 inhibitors.
    Type: Application
    Filed: August 28, 2020
    Publication date: September 8, 2022
    Inventors: Martin BOLLI, John GATFIELD, Corinna GRISOSTOMI, Lubos REMEN, Christoph SAGER, Cornelia ZUMBRUNN